LG
Leland Gershell Oppenheimer Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Xeris Biopharma Holdings
XERS
$1.29B
| $7.96 | $8 |
1%
upside
| Outperform | 26 days ago |
|
2
Viridian Therapeutics
VRDN
$1.61B
| $19.76 | $32 |
62%
upside
| Outperform | 27 days ago |
|
3
Soleno Therapeutics
SLNO
$3.6B
| $67.68 | $110 |
63%
upside
| Outperform | 27 days ago |
|
4
BridgeBio Pharma
BBIO
$9.98B
| $52.21 | $61 |
17%
upside
| Outperform | 28 days ago |
|
5
Alnylam Pharmaceuticals
ALNY
$59.5B
| $453.68 | $490 |
8%
upside
| Outperform | 1 month ago |
|
6
Lexeo Therapeutics
LXEO
$261M
| $4.83 | $20 |
314%
upside
| Outperform | 1 month ago |
|
7
Rhythm Pharmaceuticals
RYTM
$6.94B
| $104.47 | $110 |
5%
upside
| Outperform | 1 month ago |
|
8
Capricor Therapeutics
CAPR
$293M
| $6.41 | $22 |
243%
upside
| Outperform | 2 months ago |
|
9
Ascendis Pharma
ASND
$12.2B
| $201.35 | $224 |
11%
upside
| Outperform | 2 months ago |
|
10
UroGen Pharma
URGN
$907M
| $19.60 | $31 |
58%
upside
| Outperform | 2 months ago |
|
11
argenx
ARGX
$43.6B
| $711.63 | $708 |
1%
downside
| Outperform | 3 months ago |
|
12
Trevi Therapeutics
TRVI
$869M
| $7.14 | $20 |
180%
upside
| Outperform | 5 months ago |
|
13
BioMarin Pharmaceuticals
BMRN
$11.4B
| $59.56 | $98 |
65%
upside
| Outperform | 6 months ago |
|
14
Dianthus Therapeutics
DNTH
$777M
| $24.14 | $52 |
115%
upside
| Outperform | 9 months ago |
|
15
Ligand Pharmaceuticals
LGND
$3.22B
| $165.43 | $147 |
11%
downside
| Outperform | 9 months ago |
|
16
Immunovant
IMVT
$2.71B
| $15.55 | $53 |
241%
upside
| Outperform | 10 months ago |
|
17
Crinetics Pharmaceuticals
CRNX
$3.25B
| $34.56 | $73 |
111%
upside
| Outperform | 1 year ago |
|
18
Catalyst Pharmaceutical
CPRX
$2.56B
| $20.88 | $29 |
39%
upside
| Outperform | 1 year ago |
|